Techbio company building liquid-biopsy solutions for cancer detection
| Date | Round | Amount |
|---|---|---|
| Sep 2022 | Seed Hedera Dx, a Swiss liquid-biopsy techbio, raised €14M led by Top Harvest Capital to launch blood-based cancer testing. | $14M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.